ASP Isotopes (ASPI) announced that, effective January 19, 2026, Paul Mann, the founder and Executive Chairman of ASP Isotopes, will resume his role as the Company’s CEO and continue as Executive Chairman. On September 29, 2025, it was announced that Mr. Mann would be taking a temporary leave of absence from his CEO duties for health reasons, and that the Company’s Board of Directors had appointed Robert Ainscow, the Company’s COO, to serve as Interim CEO in addition to his current duties. Mr. Mann is now able to travel again and he will resume full day-to-day CEO duties as of January 19, 2026. Ainscow will continue in his position as COO.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ASPI:
- Unusually active option classes on open November 21st
- ASP Isotopes Inc options imply 6.1% move in share price post-earnings
- ASP Isotopes Announces $64.3M Convertible Note Agreement
- ASP Isotopes Inc options imply 15.3% move in share price post-earnings
- ASP Isotopes Inc call volume above normal and directionally bullish